Bhagwan Dass Pharmaceutical Limited

Founded in 2020 and headquartered in Delhi, India.

2020 | Delhi (India) | Active
Last Updated:

Bhagwan Dass Pharmaceutical Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -35.97%
  • Profit Growth 47.05%
  • Ebitda -492.78%
  • Net Worth -12.08%
  • Total Assets 15.95%

About Bhagwan Dass Pharmaceutical

Bhagwan Dass Pharmaceutical Limited (BDPL) is a Public Limited Indian Non-Government Company incorporated in India on 21 January 2020 (Five years and one month 20 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Rekha Sareen, Namrata Arora, and Prajwal Arora serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24304DL2020PLC360532

  • Company No.

    360532

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    21 Jan 2020

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma
Company report

Bhagwan Dass Pharmaceutical Limited

Explore comprehensive data for Bhagwan Dass Pharmaceutical Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Bhagwan Dass Pharmaceutical?

Board Members (3)

NameDesignationAppointment DateStatus
Rekha Sareen Country flag representing In Director 21-Jan-2020Current
Namrata Arora Country flag representing In Director 24-Aug-2024Current
Prajwal Arora Country flag representing In Director 21-Jan-2020Current

Financial Performance of Bhagwan Dass Pharmaceutical.

Bhagwan Dass Pharmaceutical Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.97% decrease. The company also saw a substantial improvement in profitability, with a 47.05% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.08%.

Bhagwan Dass Pharmaceutical revenue growth over time
Bhagwan Dass Pharmaceutical profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-35.97%
Revenue from Operations
Total Assets
15.95%
Profit or Loss
47.05%
Net Worth
-12.08%
EBITDA
-492.78%

What is the Ownership and Shareholding Structure of Bhagwan Dass Pharmaceutical?

Unlock access to Bhagwan Dass Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Bhagwan Dass Pharmaceutical?

Unlock and access historical data on people associated with Bhagwan Dass Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Bhagwan Dass Pharmaceutical Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bhagwan Dass Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhagwan Dass Pharmaceutical's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Bhagwan Dass Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Bhagwan Dass Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Namrata Arora was appointed as a Director was appointed as a Director on 24 Aug 2024 & has been associated with this company since 6 months 19 days .

  • Balance Sheet

    Bhagwan Dass Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

  • Director Appointment

    Rekha Sareen was appointed as a Director was appointed as a Director on 21 Jan 2020 & has been associated with this company since 5 years 1 month .

  • Director Appointment

    Prajwal Arora was appointed as a Director was appointed as a Director on 21 Jan 2020 & has been associated with this company since 5 years 1 month .

  • Company Incorporation

    Bhagwan Dass Pharmaceutical Limited was registered on 21 Jan 2020 with Roc Delhi & aged 5 years 1 month as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Bhagwan Dass Pharmaceutical Limited?

    Bhagwan Dass Pharmaceutical Limited was incorporated on 21 Jan 2020.

  • What is authorized share capital and paid-up capital of Bhagwan Dass Pharmaceutical Limited?

    The authorized share capital of Bhagwan Dass Pharmaceutical Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Bhagwan Dass Pharmaceutical Limited?

    Currently 3 directors are associated with Bhagwan Dass Pharmaceutical Limited.

    • Rekha Sareen
    • Namrata Arora
    • Prajwal Arora
  • What is the registered address of Bhagwan Dass Pharmaceutical Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Bhagwan Dass Pharmaceutical Limited is 1495 G/F Shankar Niwas, Building Niwas Bhagirath Palace India, New Delhi, 110006.

  • What is the corporate identification number (CIN) and company number of Bhagwan Dass Pharmaceutical Limited?

    The corporate identification number (CIN) of Bhagwan Dass Pharmaceutical Limited is U24304DL2020PLC360532 and the company number is 360532 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Bhagwan Dass Pharmaceutical Limited?

    According to the financial reports for the fiscal year 2022, the revenue trend for Bhagwan Dass Pharmaceutical Limited has fallen by -35.97%.

  • What change has been observed in the net worth of Bhagwan Dass Pharmaceutical Limited, and by what percentage?

    The financial reports for the fiscal year 2022 indicates that The net worth of Bhagwan Dass Pharmaceutical Limited has experienced an downturn of -12.08%.

  • When was the last Balance Sheet of Bhagwan Dass Pharmaceutical Limited filed with the ROC?

    The most recent Balance Sheet for Bhagwan Dass Pharmaceutical Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed